NCT03317977

Brief Summary

The propose of the study is to test the effectiveness of Reach for Control (RFC) as compared to Michigan MATCH to improve asthma symptoms, asthma management and lung functioning and to decrease ED visits and admissions for youth with poorly controlled asthma when integrated into hospital emergency departments and delivered by community health workers. The study is a hybrid implementation-effectiveness design and will test RFC for use in real world, public healthcare settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 23, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2023

Completed
8 months until next milestone

Results Posted

Study results publicly available

April 4, 2024

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

5.5 years

First QC Date

October 18, 2017

Results QC Date

February 19, 2024

Last Update Submit

April 1, 2024

Conditions

Keywords

Asthma management, adolescents

Outcome Measures

Primary Outcomes (1)

  • Number of Emergency Department Visits

    Emergency department visits will be obtained from electronic medical records

    Change from Baseline at 6 months, 12 months, and 18 months

Secondary Outcomes (2)

  • Family Asthma Management System Scale

    Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months

  • Asthma Symptom Frequency

    Change from Baseline at 6 months, change from Baseline at 12 months and change from Baseline at 18 months

Study Arms (2)

Reach for Control

EXPERIMENTAL

Reach For Control is a multi-component, home-based family therapy that targets the multiple causes of poor adolescent asthma management across individual, family and community systems.

Behavioral: Reach for Control

Michigan MATCH

ACTIVE COMPARATOR

Program endorsed by the State of Michigan for treatment of poorly controlled asthma.

Behavioral: MATCH

Interventions

In Phase 1 (weeks 1-4), the CHW conducts an initial intake and then completes a comprehensive functional analysis (FA) of behavior to determine the causes of poor asthma management for each youth regarding asthma management. In Phase 2 (weeks 5-20) is a treatment phase and consists of a combination of mandatory cognitive-behavioral skills training (CBST) modules (received by all families) and flexible CBST modules chosen and individualized based on the results of the Phase 1 FA. This includes but not limited to In-vivo Asthma Skills Training, Improving Family Communication and Behavioral Contracting. Phase 3 (weeks 21-24) involves termination planning and relapse prevention

Also known as: RFC
Reach for Control
MATCHBEHAVIORAL

Managing Asthma Through Case Management in Home (MATCH) is the current intervention provided by WCHAP to youth with poorly controlled asthma and their families.

Michigan MATCH

Eligibility Criteria

Age12 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Adolescent/Parent:
  • Child aged 12 years, 0 months to 16 years, 11 months
  • Moderate to severe persistent asthma
  • Child seen in the CHM emergency department for treatment of asthma exacerbation
  • Child has experienced 2 or more ED visits and/ or inpatient admissions in prior 12 months (i.e. poorly controlled asthma)
  • Parent/ legal guardian willing to participate in home-based family treatment
  • Child and family resides within 20 miles of CHM (allows for home-based data collection and intervention)

You may not qualify if:

  • Adolescent/Parent:
  • Child is currently in an out-of-home placement
  • Schizophrenia or other psychosis on the part of the youth or parent
  • Current suicidality or homicidality on the part of the youth or parent
  • Cognitive impairment or learning disability that prevents comprehension of research measures on the part of parent or youth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Michigan

Detroit, Michigan, 48201, United States

Location

Results Point of Contact

Title
Deborah Ellis, Ph.D.
Organization
Wayne State University

Study Officials

  • Deborah A Ellis, Ph.D

    Wayne State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Family Medicine and Public Health Sciences

Study Record Dates

First Submitted

October 18, 2017

First Posted

October 23, 2017

Study Start

February 1, 2018

Primary Completion

August 8, 2023

Study Completion

August 8, 2023

Last Updated

April 4, 2024

Results First Posted

April 4, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Data will be made available at the end of the study through presentations at scientific conferences and publications in peer-reviewed scientific journals. All final peer-reviewed manuscripts that result from the study will be submitted to PubMed Central. In addition, final dataset from the trial will be shared. Identifiers will be removed from the data prior to any release of the dataset.

Time Frame
Indefinitely
Access Criteria
In light of the sensitive nature of the treatment data contained in the data set, as well as the participation of children, data and associated documentation will be made available to users only under a specific data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying the data after analyses are completed. Furthermore, audiotaped session recordings will not be shared, as these include voice identifiers and it is not possible to de-identify the recordings; costs of transcription of sessions given their length and number are beyond the scope of the study.

Locations